Sort by
Refine Your Search
-
Employer
-
Field
-
dysfunction in neurodegenerative and neuromuscular disorders. The researcher will be based at the Institute of Biotechnology, University of Helsinki. The Institute provides state-of-the-art research
-
disrupt cellular energy metabolism and drive progressive dysfunction in neurodegenerative and neuromuscular disorders. The researcher will be based at the Institute of Biotechnology, University of
-
human genetics, gene therapy, CRISPR-based gene editing, stem cell technologies, and translational disease modelling. We are particularly interested in developing treatments for retinal disorders
-
treatments for retinal disorders prevalent in the Finnish population and advancing promising therapeutic strategies toward clinical application. The group collaborates extensively with national and